Literature DB >> 16714939

Unrecognized side effect of statin treatment: unilateral blepharoptosis.

Fatih Sinan Ertas1, Nilgün Markal Ertaş, Sadi Gulec, Yusuf Atmaca, Sumru Tanju, Cumhur Sener, Cetin Erol.   

Abstract

A 43-year-old man receiving statin monotherapy (10 mg atorvastatin) for hypercholesterolemia had unilateral blepharoptosis as the result of isolated myositis of the levator muscle. Statin-induced myositis in the levator muscle should be considered in the differential diagnosis of acquired unilateral blepharoptosis of unknown cause.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714939     DOI: 10.1097/01.iop.0000217573.90522.48

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Statin-associated ocular disorders: the FDA and ADRAC data.

Authors:  Vinci Mizranita; Eko Harry Pratisto
Journal:  Int J Clin Pharm       Date:  2015-05-05

2.  Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Michele Spina; Chi Nhan Tran; Maurizio Falconi; Anna Maria Eleuteri; Mauro Angeletti
Journal:  J Lipid Res       Date:  2011-02-25       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.